bupa Arabia for Cooperative Insurance

The company has developed into one of Saudi Arabia’s largest health insurers, with its expansion closely linked to the growth of compulsory medical insurance, private-sector employment and the wider transformation of healthcare in the kingdom.

The business traces its Saudi operations to a partnership between international healthcare group Bupa and the Nazer Group. Bupa Arabia subsequently became a Saudi joint-stock company and listed on the Saudi Exchange in 2008. Loay Hisham Nazer serves as chairman, while Tal Hisham Nazer is chief executive and an executive director.

Its financial scale continued to increase in 2025. Insurance revenue rose 6.6 per cent to SAR19.30bn from SAR18.10bn in 2024, while gross written premiums increased 11.4 per cent to SAR20.49bn. However, net profit attributable to shareholders fell 7.5 per cent to SAR1.08bn as insurance-service profitability was affected by inflationary pressures and higher operating expenditure. Net investment results increased 8.7 per cent to SAR730.7m.

Growth strengthened during the first half of 2026. Insurance revenue increased 15.5 per cent year on year to SAR10.54bn, while gross written premiums rose 11.8 per cent to SAR13.45bn. Net profit attributable to shareholders increased 4.1 per cent to SAR694.1m. The net insurance service result reached SAR605.1m, up 4.3 per cent, while net investment results increased 11.2 per cent to SAR412.3m.

Bupa Arabia’s development increasingly extends beyond the traditional role of reimbursing medical claims. The company has invested in digital healthcare interactions, member services and healthcare administration as Saudi Arabia seeks greater private-sector participation in healthcare delivery.

That shift gives insurers a broader role in managing patient journeys and health outcomes. Digital approvals, preventative-care programmes, healthcare data and member engagement can help insurers manage both customer experience and the cost of treatment. Saudi Arabia’s demographic growth, expanding workforce and healthcare reforms continue to provide a substantial addressable market. At the same time, medical inflation creates pressure on underwriting margins, making pricing discipline and healthcare-cost management increasingly important.